introduction this case report describes a patient who developed rhabdomyolysis temporally associated with the use of a mislabeled acai berry dietary supplementmethods and results the authors describe a 22yearold man presenting with rhabdomyolysis approximately 2 weeks after starting a weightloss dietary supplementhis medical history was significant only for hypertension treated with amlodipinethe diagnosis of rhabdomyolysis was confirmed creatine kinase 84000 iul positive urine myoglobin with other potential causes ruled outthe signs and symptoms of the patient gradually resolved and he was discharged on hospital day 5assessment using the naranjo adverse drug reaction probability scale yielded a score of 3 indicating a possible relationship between the supplement and rhabdomyolysisalthough the product was labeled and promoted as containing acai berry and additional ingredients there was no acai berry found on analysisconclusion clinicians should be aware that all dietary supplements may vary in uniformity and contain unknown contaminants